First real-world studies report glecaprevir/pibrentasvir to be effective and well tolerated in chronic HCV infection

Studies conducted in Italy and Germany confirm the effectiveness and safety of glecaprevir/pibrentasvir in patients with chronic hepatitis C virus infection, with viral suppression rates similar to those observed in clinical trials.

What feeling does this article give you?
Joy
Disgust
Fear
Anger
Sadness

#hashtags to follow:

Italy and Germany [+]   

More #news: